Who says you have to be a mega-conglomerate in order to pursue a spinoff? Galena Biopharma (GALE), a $46m market cap biotech company, announced that it will spin off RXi Pharmaceutical via stock dividend sometime in the coming months. While the board has not set a final payment date, the date of record will...
Read More »
Monthly Archives: February 2012
Galena Biopharma Divvying Up Its RNA Business
NovaGold Further Details Its NovaCopper Spin
NovaGold (NG) recently provided an update on its planned spinoff of its Northern Alaska Ambler copper deposits. Since that doesn’t quite roll off the tongue, the new company will be known as NovaCopper. Click here for our earlier article on this topic. Shareholders of NovaGold will receive 1 share of NovaCopper for every 6 shares...
Read More »
Paulson To Hartford Financial – Spin Or Else?
Listening to (or reading) company conference calls are a necessary but often painful part of investing. Calls are usually filled with a bunch of numbers, some CEO speak and suck-up analysts (if the company is doing well) so anything out of the ordinary or even somewhat controversial becomes noteworthy. Throw in ‘legendary’ fund manager...
Read More »
The Joys Of Activist Investing
Ah, to be an activist investor. Push around executives, demand ‘shareholder friendly’ measures and all this while maintaining the flexibility of trading in and out of shares. After pushing hard for a breakup, Carl Icahn quickly rang the register on a chunk of his Motorola Mobility (MMI) stake shortly after its takeout announcement. Too...
Read More »
